ARCHIVES

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

This article is from The Cancer Letter archive.

Vol. 19 No. 14 | April 2, 1993

Download PDF Visit The Full Archive

Related Articles

In Brief: Bleyer To Chair Childrens Cancer Study Group; Fisher To Advise; Penn. Awards Herberman

May 3, 1991

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

Niccotine Reports As Aiding Metastasis

August 22, 1986

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

July 25, 2014

UICC Fellowship, Exchange Programs

July 5, 1985

NCAB Approves CCP, Agrees To Compromise On Including Control

May 21, 1982